Atlas Trials

Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study

Clinical trial NCT05983835 · UNKNOWN

Trial details

NCT number
NCT05983835
Sponsor
Fujian Medical University Union Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
IA Lung AdenocarcinomaCombined Segmentectomy
Start date
2022-10-01
Primary completion
2024-10-01
Enrollment
688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.